Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-28 Purchase | 2024-04-01 4:01 pm | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 30,000 | $3.859 | $115,770 | 30,000 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 4:17 pm | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 206 | $2.46 | $507 | 12,299 (Direct) | View |
| 2023-12-07 Sale | 2023-12-14 4:01 pm | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 1,820 | $2.5 | $4,550 | 4,855 (Direct) | View |
| 2022-05-25 Purchase | 2022-05-27 4:10 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | 2,482 | $2.58 | $6,404 | 232,558 (Indirect Direct) | View |
| 2022-05-19 Purchase | 2022-05-23 4:41 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | 13,256 | $2.7938 | $37,034 | 230,076 (Indirect Direct) | View |
| 2022-05-19 Purchase(A) | 2022-05-23 4:00 pm | Gain Therapeutics Inc. | GANX | Calabrese Salvatore CHIEF FINANCIAL OFFICER | 3,000 | $2.7 | $8,100 | 3,000 (Direct) | View |
| 2022-05-19 Purchase(M) | 2022-05-19 5:00 pm | Gain Therapeutics Inc. | GANX | Calabrese Salvatore CHIEF FINANCIAL OFFICER | 3,000 | $2.7 | $8,100 | 8,100 (Direct) | View |
| 2021-08-16 Purchase(A) | 2022-04-21 4:50 pm | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer | 4,922 | $7.866 | $38,716 | 216,820 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-08 Option Award | 2024-04-08 7:44 pm | N/A 2034-04-08 | Gain Therapeutics Inc. | GANX | Mack Gene Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-03-26 Tax Withholding | 2024-03-28 9:00 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 6,085 | $4.06 | 92,016 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-28 9:00 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 20,212 | $0 | 92,016 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 9:30 pm | N/A 2034-03-21 | Gain Therapeutics Inc. | GANX | Fuggetta Gianluca See Remark | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 9:30 pm | N/A 2034-03-21 | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 370,000 | $0 | 370,000 (Direct) | View |
| 2023-12-20 Exercise | 2023-12-22 4:17 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 637 | $0 | 12,299 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-03 4:36 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 825 | $0 | 15,750 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:34 pm | N/A N/A | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 54,900 | $0 | 287,458 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:34 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 2,550 | $0 | 13,500 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:18 pm | N/A N/A | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 3,300 | $0 | 13,200 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:40 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Islam Khalid Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:39 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:38 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:38 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:37 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | Nicaise Claude Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:36 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-12 5:36 pm | N/A 2033-04-10 | Gain Therapeutics Inc. | GANX | Ballantyne Charles Evan Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 5:28 pm | N/A 2033-03-23 | Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 5:27 pm | N/A 2033-03-23 | Gain Therapeutics Inc. | GANX | Fuggetta Gianluca Principal Accounting Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-27 5:26 pm | N/A 2033-03-23 | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Executive Officer | 225,000 | $0 | 225,000 (Direct) | View |
Ownership | 2022-12-21 4:14 pm | N/A 2032-06-30 | Gain Therapeutics Inc. | GANX | Fuggetta Gianluca Principal Accounting Officer | 0 | $0 | 10,000 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:14 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Director | 384,300 | $0 | 384,300 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:13 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Islam Khalid Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:11 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Riley Jeffrey Scott Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:10 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:09 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Melincoff Gwen A Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:08 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Nicaise Claude Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:07 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | HASLER HANS PETER Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:06 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Operating Officer | 71,100 | $0 | 71,100 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:37 pm | N/A 2032-07-15 | Gain Therapeutics Inc. | GANX | Calabrese Salvatore Chief Financial Officer | 69,300 | $0 | 69,300 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:36 pm | N/A 2032-07-15 | Gain Therapeutics Inc. | GANX | Alder Matthias Chief Operating Officer | 92,400 | $0 | 92,400 (Direct) | View |
Ownership(A) | 2022-04-21 4:47 pm | N/A 2030-12-15 | Gain Therapeutics Inc. | GANX | RICHMAN ERIC I Chief Executive Officer | 0 | $0 | 26,424 (Direct) | View |